New drug MT-2990 tested in rare blood vessel disease
NCT ID NCT06196905
First seen Dec 16, 2025 · Last updated Jun 21, 2026 · Updated 30 times
Summary
This early study looked at a new drug, MT-2990, in 5 people with ANCA-associated vasculitis, a rare disease where the immune system attacks blood vessels. The goal was to see if the drug is safe and how it affects disease activity. Researchers measured changes in symptoms, imaging, and lab tests, but no single main outcome was set.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hiroshima University Hospital
Hiroshima, Hiroshima, 734-8551, Japan
-
Juntendo University Hospital
Bunkyo-ku, Tokyo, 113-8431, Japan
-
Kagawa University Hospital
Kita-gun, Kagawa-ken, 761-0793, Japan
-
Keio University Hospital
Shinjuku-ku, Tokyo, 160-8582, Japan
-
Kyorin University Hospital
Mitaka-shi, Tokyo, 181-8611, Japan
-
NHO Tokyo Medical Center
Meguro-ku, Tokyo, 152-8902, Japan
-
Saitama Medical Center
Kawagoe, Saitama, 350-8550, Japan
-
Saitama Medical University Hospital
Iruma-gun, Saitama, 350-0495, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.